Review article: The current and evolving treatment of colonic diverticular disease

Alimentary Pharmacology and Therapeutics

Volumn 30, Issue 6, 2009, Pages 532-546

  Tursi, A ^a   Papagrigoriadis, S ^b  

^a 'Lorenzo Bonomo' Hospital   (Italy)

^b KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; BALSALAZIDE; C REACTIVE PROTEIN; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORIN; CIPROFLOXACIN; CLINDAMYCIN; CYTOKINE; GAMMA INTERFERON; GENTAMICIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 11; INTERLEUKIN 4; LACTOBACILLUS CASEI EXTRACT; MESALAZINE; METRONIDAZOLE; MORPHINE; PENTACOL; PETHIDINE; PIPERACILLIN; PROBIOTIC AGENT; RIFAXIMIN; SULTAMICILLIN; TAZOBACTAM; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ABDOMINAL ABSCESS; ACUTE DISEASE; ADD ON THERAPY; AEROBIC BACTERIUM; AGE DISTRIBUTION; ANAEROBIC BACTERIUM; ANTIBIOTIC THERAPY; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; BACTERIAL OVERGROWTH; BACTERIUM ADHERENCE; BIFIDOBACTERIUM; BLOATING; COLON BIOPSY; COLON DIVERTICULOSIS; COLON FLORA; COLON RESECTION; COMBINATION CHEMOTHERAPY; CONSTIPATION; CONTINUOUS INFUSION; CYTOKINE PRODUCTION; DIARRHEA; DIET SUPPLEMENTATION; DIET THERAPY; DIETARY FIBER; DISEASE CLASSIFICATION; DISEASE SEVERITY; DRUG CHOICE; ENTERITIS; ERYTHROCYTE SEDIMENTATION RATE; FISTULA; HEALTH SURVEY; HUMAN; IMMUNOMODULATION; INTESTINE PERFORATION; LACTIC ACID BACTERIUM; LACTOBACILLUS RHAMNOSUS; LAPAROSCOPIC SURGERY; LIFESTYLE MODIFICATION; LOWER ABDOMINAL PAIN; MEAT; MEDLINE; MICROBIOLOGY; MONOTHERAPY; MUCOSA INFLAMMATION; MULTIDETECTOR COMPUTED TOMOGRAPHY; MULTIPLE CYCLE TREATMENT; NUT; PATHOPHYSIOLOGY; PERITONITIS; PHLEGMON; PHYSICAL ACTIVITY; PHYSICIAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; RECURRENT DISEASE; RELAPSE; REVIEW; RISK FACTOR; SEED; SEPSIS; SMALL INTESTINE OBSTRUCTION; SMOKING; TENESMUS; TREATMENT OUTCOME;

ANTI-BACTERIAL AGENTS; DIETARY SUPPLEMENTS; DIVERTICULITIS, COLONIC; GASTROINTESTINAL AGENTS; HUMANS; MESALAMINE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECURRENCE; RIFAMYCINS; RISK FACTORS;

EID: 68949203592     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2009.04072.x     Document Type: Review

References (133)

1. Telling WHM. Discussion on diverticulitis. Proc R Soc Med 1920 13 : 55 64.
2. Painter NS, Burkitt DP. Diverticular disease of the colon: a deficiency disease of Western civilization. Br Med J 1971 2 : 450 4.
3. Hughes LE. Postmortem survey of diverticular disease of the colon. I. Diverticulosis and diverticulitis. Gut 1969 10 : 336 44.
4. Hjern F, Josephson T, Altman D, et al. Conservative treatment of acute colonic diverticulitis: are antibiotics always mandatory? Scand J Gastroenterol 2007 42 : 41 7.
5. Comparato G, Pilotto A, Franze A, et al. Diverticular disease in the elderly. Dig Dis 2007 25 : 151 9.
6. Jun S, Stollman N. Epidemiology of diverticular disease. Best Pract Res Clin Gastroenterol 2002 16 : 529 42.
7. Bogardus ST Jr. What do we know about diverticular disease? A brief overview. J Clin Gastroenterol 2006 40 : S108 11.
8. Hjern F, Johansson C, Mellgren A, et al. Diverticular disease and migration - the influence of acculturation to a Western lifestyle on diverticular disease. Aliment Pharmacol Ther 2006 23 : 797 805.
9. Parks TG. Natural history of diverticular disease of the colon. Clin Gastroenterol 1975 4 : 53 69.
10. Aydin HN, Remzi FH. Diverticulitis: when and how to operate? Dig Liver Dis 2004 36 : 435 45.
11. Boles RS Jr., Jordan SM. The clinical significance of diverticulosis. Gastroenterology 1958 35 : 579 82.
12. Rafferty J, Shellito P, Hyman NH, et al. Practice parameters for sigmoid diverticulitis. Dis Colon Rectum 2006 49 : 939 44.
13. Aldoori WH, Giovannucci EL, Rimm EB, et al. A prospective study of diet and the risk of symptomatic diverticular disease in men. Am J Clin Nutr 1994 60 : 757 64.
14. Aldoori W, Ryan-Harshman M. Preventing diverticular disease. Review of recent evidence on high-fibre diets. Can Fam Physician 2002 48 : 1632 7.
15. Aldoori WH, Giovannucci EL, Rockett HR, et al. A prospective study of dietary fiber types and symptomatic diverticular disease in men. J Nutr 1998 128 : 714 9.
16. Korzenik JR. Case closed? Diverticulitis: epidemiology and fiber. J Clin Gastroenterol 2006 40 : S112 6.
17. Floch MH, Bina I. The natural history of diverticulitis: fact and theory. J Clin Gastroenterol 2004 38 : S2 7.
18. Floch MH, White JA. Management of diverticular disease is changing. World J Gastroenterol 2006 12 : 3225 8.
19. Steel M. Colonic diverticular disease. Aust Fam Physician 2004 33 : 983 6.
20. Salzman H, Lillie D. Diverticular disease: diagnosis and treatment. Am Fam Physician 2005 72 : 1229 34.
21. Stollman N, Raskin JB. Diverticular disease of the colon. Lancet 2004 363 : 631 9.
22. Stollman NH, Raskin JB. Diagnosis and management of diverticular disease of the colon in adults. Ad Hoc Practice Parameters Committee of the American College of Gastroenterology. Am J Gastroenterol 1999 94 : 3110 21.
23. Ibele A, Heise CP. Diverticular disease: update. Curr Treat Options Gastroenterol 2007 10 : 248 56.
24. Parra-Blanco A. Colonic diverticular disease: pathophysiology and clinical picture. Digestion 2006 73 (Suppl 1) 47 57.
25. Kohler L, Sauerland S, Neugebauer E. Diagnosis and treatment of diverticular disease: results of a consensus development conference. The Scientific Committee of the European Association for Endoscopic Surgery. Surg Endosc 1999 13 : 430 6.
26. Tursi A. New physiopathological and therapeutic approaches to diverticular disease of the colon. Expert Opin Pharmacother 2007 8 : 299 307.
27. Hinchey EJ, Schaal PG, Richards GK. Treatment of perforated diverticular disease of the colon. Adv Surg 1978 12 : 85 109.
28. Morini S, Zullo A, Hassan C, et al. Diverticulosis and colorectal cancer: between lights and shadows. J Clin Gastroenterol 2008 42 : 763 70.
29. Schechter S, Mulvey J, Eisenstat TE. Management of uncomplicated acute diverticulitis: results of a survey. Dis Colon Rectum 1999 42 : 470 5.
30. Horner JL. Natural history of diverticulosis of the colon. Am J Dig Dis. 1958 3 : 343 50.
31. Jacobs DO. Clinical practice. Diverticulitis. N Engl J Med 2007 357 : 2057 66.
32. Fleischner FG, Ming SC. Revised concepts on diverticular disease of the colon. II. So-called diverticulitis: diverticular sigmoiditis and perisigmoiditis; diverticular abscess, fistula, and frank peritonitis. Radiology 1965 84 : 599 609.
33. Manousos O, Day NE, Tzonou A, et al. Diet and other factors in the aetiology of diverticulosis: an epidemiological study in Greece. Gut 1985 26 : 544 9.
34. Lin OS, Soon MS, Wu SS, et al. Dietary habits and right-sided colonic diverticulosis. Dis Colon Rectum 2000 43 : 1412 8.
35. Gear JS, Ware A, Fursdon P, et al. Symptomless diverticular disease and intake of dietary fibre. Lancet 1979 1 : 511 4.
36. Lakatos PL, Szamosi T, Lakatos L. Smoking in inflammatory bowel diseases: good, bad or ugly? World J Gastroenterol 2007 13 : 6134 9.
37. Papagrigoriadis S, Macey L, Bourantas N, et al. Smoking may be associated with complications in diverticular disease. Br J Surg 1999 86 : 923 6.
38. Aldoori WH, Giovannucci EL, Rimm EB, et al. A prospective study of alcohol, smoking, caffeine, and the risk of symptomatic diverticular disease in men. Ann Epidemiol 1995 5 : 221 8.
39. Aldoori WH, Giovannucci EL, Rimm EB, et al. Prospective study of physical activity and the risk of symptomatic diverticular disease in men. Gut 1995 36 : 276 82.
40. Gronlund MM, Arvilommi H, Kero P, et al. Importance of intestinal colonisation in the maturation of humoral immunity in early infancy: a prospective follow up study of healthy infants aged 0-6 months. Arch Dis Child Fetal Neonatal Ed 2000 83 : F186 92.
41. Kirjavainen PV, Apostolou E, Arvola T, et al. Characterizing the composition of intestinal microflora as a prospective treatment target in infant allergic disease. FEMS Immunol Med Microbiol 2001 32 : 1 7.
42. Falk PG, Hooper LV, Midtvedt T, et al. Creating and maintaining the gastrointestinal ecosystem: what we know and need to know from gnotobiology. Microbiol Mol Biol Rev 1998 62 : 1157 70.
43. Ouwehand AC, Salminen S, Roberts PJ, et al. Disease-dependent adhesion of lactic acid bacteria to the human intestinal mucosa. Clin Diagn Lab Immunol 2003 10 : 643 6.
44. Guarner F, Malagelada JR. Gut flora in health and disease. Lancet 2003 361 : 512 9.
45. Si JM, Yu YC, Fan YJ, et al. Intestinal microecology and quality of life in irritable bowel syndrome patients. World J Gastroenterol 2004 10 : 1802 5.
46. Malinen E, Rinttila T, Kajander K, et al. Analysis of the fecal microbiota of irritable bowel syndrome patients and healthy controls with real-time PCR. Am J Gastroenterol 2005 100 : 373 82.
47. Favier C, Neut C, Mizon C, et al. Fecal beta-D-galactosidase production and Bifidobacteria are decreased in Crohn's disease. Dig Dis Sci 1997 42 : 817 22.
48. Manichanh C, Rigottier-Gois L, Bonnaud E, et al. Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach. Gut 2006 55 : 205 11.
49. Hope ME, Hold GL, Kain R, et al. Sporadic colorectal cancer - role of the commensal microbiota. FEMS Microbiol Lett 2005 244 : 1 7.
50. Colecchia A, Sandri L, Capodicasa S, et al. Diverticular disease of the colon: new perspectives in symptom development and treatment. World J Gastroenterol 2003 9 : 1385 9.
51. Ouwehand AC, Salminen S, Arvola T, et al. Microbiota composition of the intestinal mucosa: association with fecal microbiota? Microbiol Immunol 2004 48 : 497 500.
52. Gueimonde M, Ouwehand A, Huhtinen H, et al. Qualitative and quantitative analyses of the bifidobacterial microbiota in the colonic mucosa of patients with colorectal cancer, diverticulitis and inflammatory bowel disease. World J Gastroenterol 2007 13 : 3985 9.
53. Brook I, Frazier EH. Aerobic and anaerobic microbiology in intra-abdominal infections associated with diverticulitis. J Med Microbiol 2000 49 : 827 30.
54. Rogler G, Andus T. Cytokines in inflammatory bowel disease. World J Surg 1998 22 : 382 9.
55. Tursi A. Mesalazine for diverticular disease of the colon - a new role for an old drug. Expert Opin Pharmacother 2005 6 : 69 74.
56. Russ MA, Reith HB. The severity of infection induces a shift in the type 1/Type 2 T-helper cell balance in patients with or without peritonitis. Surg Infect (Larchmt) 2003 4 : 247 54.
57. Singer II, Kawka DW, Scott S, et al. Expression of inducible nitric oxide synthase and nitrotyrosine in colonic epithelium in inflammatory bowel disease. Gastroenterology 1996 111 : 871 85.
58. Blokzijl H, Vander BS, Bok LI, et al. Decreased P-glycoprotein (P-gp/MDR1) expression in inflamed human intestinal epithelium is independent of PXR protein levels. Inflamm Bowel Dis 2007 13 : 710 20.
59. Boirivant M, Marini M, Di FG, et al. Lamina propria T cells in Crohn's disease and other gastrointestinal inflammation show defective CD2 pathway-induced apoptosis. Gastroenterology 1999 116 : 557 65.
60. Ghorai S, Ulbright TM, Rex DK. Endoscopic findings of diverticular inflammation in colonoscopy patients without clinical acute diverticulitis: prevalence and endoscopic spectrum. Am J Gastroenterol 2003 98 : 802 6.
61. Tursi A, Brandimarte G, Giorgetti G, et al. The clinical picture of uncomplicated versus complicated diverticulitis of the colon. Dig Dis Sci 2008 53 : 2474 9.
62. Brodribb AJ. Treatment of symptomatic diverticular disease with a high-fibre diet. Lancet 1977 1 : 664 6.
63. Painter NS. The treatment of uncomplicated diverticular disease of the colon with a high fibre diet. Acta Chir Belg 1979 78 : 359 68.
64. World Gastroenterology Organisation (WGO) Practice Guidelines 2007. Diverticular disease. http://www.worldgastroenterologyorg/assets/downloads/en/ pdf/guidelines/07-diverticular-disease.pdf. 2007; Accessed 4 February 2009.
65. Lamanna A, Orsi A. In vitro activity of rifaximin and rifampicin against some anaerobic bacteria. Chemioterapia 1984 3 : 365 7.
66. Colecchia A, Vestito A, Pasqui F, et al. Efficacy of long term cyclic administration of the poorly absorbed antibiotic Rifaximin in symptomatic, uncomplicated colonic diverticular disease. World J Gastroenterol 2007 13 : 264 9.
67. D'Inca R, Pomerri F, Vettorato MG, et al. Interaction between rifaximin and dietary fibre in patients with diverticular disease. Aliment Pharmacol Ther 2007 25 : 771 9.
68. Latella G, Pimpo MT, Sottili S, et al. Rifaximin improves symptoms of acquired uncomplicated diverticular disease of the colon. Int J Colorectal Dis 2003 18 : 55 62.
69. Papi C, Ciaco A, Koch M, et al. Efficacy of rifaximin on symptoms of uncomplicated diverticular disease of the colon. A pilot multicentre open trial. Diverticular Disease Study Group. Ital J Gastroenterol 1992 24 : 452 6.
70. Papi C, Ciaco A, Koch M, et al. Efficacy of rifaximin in the treatment of symptomatic diverticular disease of the colon. A multicentre double-blind placebo-controlled trial. Aliment Pharmacol Ther 1995 9 : 33 9.
71. Simpson J, Spiller R. Colonic Diverticular Disease. Clin Evid 2005 14 : 543 50.
72. Chow AW. Appendicitis and diverticulitis. In: Hoeprich PD, Jordan MC, Ronald AR, eds. Infectious diseases: A treatise of infectious processes. Philadelphia: JB Lippincott, 1994 : p. 878 81.
73. Ferzoco LB, Raptopoulos V, Silen W. Acute diverticulitis. N Engl J Med 1998 338 : 1521 6.
74. Kellum JM, Sugerman HJ, Coppa GF, et al. Randomized, prospective comparison of cefoxitin and gentamicin-clindamycin in the treatment of acute colonic diverticulitis. Clin Ther 1992 14 : 376 84.
75. Frieri G, Pimpo MT, Scarpignato C. Management of colonic diverticular disease. Digestion 2006 73 (Suppl 1) 58 66.
76. Brandt D, Gervaz P, Durmishi Y, et al. Percutaneous CT scan-guided drainage vs. antibiotherapy alone for Hinchey II diverticulitis: a case-control study. Dis Colon Rectum 2006 49 : 1533 8.
77. Brodribb AJ, Humphreys DM. Diverticular disease: three studies. Part I - Relation to other disorders and fibre intake. Br Med J. 1976 1 : 424 5.
78. Brodribb AJ, Humphreys DM. Diverticular disease: three studies. Part II - Treatment with bran. Br Med J. 1976 1 : 425 8.
79. Brodribb AJ, Humphreys DM. Diverticular disease: three studies. Part III. Br Med J. 1976 1 : 428 30.
80. Chautems RC, Ambrosetti P, Ludwig A, et al. Long-term follow-up after first acute episode of sigmoid diverticulitis: is surgery mandatory?: a prospective study of 118 patients. Dis Colon Rectum 2002 45 : 962 6.
81. Krukowski ZH. Laparoscopic peritoneal lavage for generalized peritonitis due to perforated diverticulitis (Br J Surg 2008; 95: 97-101). Br J Surg 2008 95 : 531 2.
82. Janes S, Meagher A, Frizelle FA. Elective surgery after acute diverticulitis. Br J Surg 2005 92 : 133 42.
83. Schoetz DJ Jr. Diverticular disease of the colon: a century-old problem. Dis Colon Rectum 1999 42 : 703 9.
84. Guzzo J, Hyman N. Diverticulitis in young patients: is resection after a single attack always warranted? Dis Colon Rectum 2004 47 : 1187 90.
85. Kaiser AM, Jiang JK, Lake JP, et al. The management of complicated diverticulitis and the role of computed tomography. Am J Gastroenterol 2005 100 : 910 7.
86. Egger B, Peter MK, Candinas D. Persistent symptoms after elective sigmoid resection for diverticulitis. Dis Colon Rectum 2008 51 : 1044 8.
87. Franklin ME Jr., Dorman JP, Jacobs M, et al. Is laparoscopic surgery applicable to complicated colonic diverticular disease? Surg Endosc 1997 11 : 1021 5.
88. Schwandner O, Farke S, Fischer F, et al. Laparoscopic colectomy for recurrent and complicated diverticulitis: a prospective study of 396 patients. Langenbecks Arch Surg. 2004 389 : 97 103.
89. Guller U, Jain N, Hervey S, et al. Laparoscopic vs open colectomy: outcomes comparison based on large nationwide databases. Arch Surg 2003 138 : 1179 86.
90. Dwivedi A, Chahin F, Agrawal S, et al. Laparoscopic colectomy vs. open colectomy for sigmoid diverticular disease. Dis Colon Rectum 2002 45 : 1309 14.
91. Tuech JJ, Pessaux P, Rouge C, et al. Laparoscopic vs open colectomy for sigmoid diverticulitis: a prospective comparative study in the elderly. Surg Endosc 2000 14 : 1031 3.
92. Bartus CM, Lipof T, Sarwar CM, et al. Colovesical fistula: not a contraindication to elective laparoscopic colectomy. Dis Colon Rectum 2005 48 : 233 6.
93. Petruzziello L, Iacopini F, Bulajic M, et al. Review article: uncomplicated diverticular disease of the colon. Aliment Pharmacol Ther 2006 23 : 1379 91.
94. Peppercorn MA. The overlap of inflammatory bowel disease and diverticular disease. J Clin Gastroenterol 2004 38 : S8 10.
95. Di Mario F, Comparato G, Fanigliulo L, et al. Use of mesalazine in diverticular disease. J Clin Gastroenterol 2006 40 : S155 9.
96. Tomkins AM, Bradley AK, Oswald S, et al. Diet and the faecal microflora of infants, children and adults in rural Nigeria and urban U.K. J Hyg (Lond) 1981 86 : 285 93.
97. Finegold SM, Attebery HR, Sutter VL. Effect of diet on human fecal flora: comparison of Japanese and American diets. Am J Clin Nutr 1974 27 : 1456 69.
98. Floch MH, Fuchs HM. Modification of stool content by increased bran intake. Am J Clin Nutr 1978 31 : S185 9.
99. Gionchetti P, Rizzello F, Lammers KM, et al. Antibiotics and probiotics in treatment of inflammatory bowel disease. World J Gastroenterol 2006 12 : 3306 13.
100. Floch MH. A hypothesis: is diverticulitis a type of inflammatory bowel disease? J Clin Gastroenterol 2006 40 : S121 5.
101. Isolauri E, Sutas Y, Kankaanpaa P, et al. Probiotics: effects on immunity. Am J Clin Nutr 2001 73 : 444S 50S.
102. Morini S, Hassan C, Zullo A, et al. Epithelial cell proliferation of the colonic mucosa in diverticular disease: a case-control study. Aliment Pharmacol Ther 2005 21 : 1385 90.
103. Tursi A, Brandimarte G, Elisei W, et al. Epithelial cell proliferation of the colonic mucosa in different degrees of colonic diverticular disease. J Clin Gastroenterol 2006 40 : 306 11.
104. Tursi A, Brandimarte G, Elisei W, et al. Assessment and grading of mucosal inflammation in colonic diverticular disease. J Clin Gastroenterol 2008 42 : 699 703.
105. Ludeman L, Warren BF, Shepherd NA. The pathology of diverticular disease. Best Pract Res Clin Gastroenterol 2002 16 : 543 62.
106. Cianci R, Iacopini F, Petruzziello L, Cammarota G, Pandolfi F, Costamagna G. Involvement of central immunity in uncomplicated diverticular disease. Scand J Gastroenterol 2009 44 : 108 15.
107. Banerjee S, Akbar N, Moorhead J, et al. Increased presence of serotonin-producing cells in colons with diverticular disease may indicate involvement in the pathophysiology of the condition. Int J Colorectal Dis 2007 22 : 643 9.
108. Costedio MM, Coates MD, Danielson AB, et al. Serotonin signaling in diverticular disease. J Gastrointest Surg 2008 12 : 1439 45.
109. Golder M, Burleigh DE, Belai A, et al. Smooth muscle cholinergic denervation hypersensitivity in diverticular disease. Lancet 2003 361 : 1945 51.
110. Golder M, Burleigh DE, Ghali L, et al. Longitudinal muscle shows abnormal relaxation responses to nitric oxide and contains altered levels of NOS1 and elastin in uncomplicated diverticular disease. Colorectal Dis 2007 9 : 218 28.
111. Carter MJ, Lobo AJ, Travis SP. Guidelines for the management of inflammatory bowel disease in adults. Gut 2004 53 : V1 16.
112. Kornbluth A, Sachar DB. Ulcerative Colitis Practice Guidelines in Adults (Update): American College of Gastroenterology, Practice Parameters Committee. Am J Gastroenterol 2004 99 : 1371 85.
113. Cohen RD. Review article: evolutionary advances in the delivery of aminosalicylates for the treatment of ulcerative colitis. Aliment Pharmacol Ther 2006 24 : 465 74.
114. Qureshi AI, Cohen RD. Mesalamine delivery systems: do they really make much difference? Adv Drug Deliv Rev 2005 57 : 281 302.
115. Sutherland L, MacDonald JK. Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis. Cochrane Database Syst Rev 2006 : CD000543.
116. Cohen HD, Das KM. The metabolism of mesalamine and its possible use in colonic diverticulitis as an anti-inflammatory agent. J Clin Gastroenterol 2006 40 : S150 4.
117. Brandimarte G, Tursi A. Rifaximin plus mesalazine followed by mesalazine alone is highly effective in obtaining remission of symptomatic uncomplicated diverticular disease. Med Sci Monit 2004 10 : I70 3.
118. Comparato G, Fanigliulo L, Cavallaro LG, et al. Prevention of complications and symptomatic recurrences in diverticular disease with mesalazine: a 12-month follow-up. Dig Dis Sci 2007 52 : 2934 41.
119. Comparato G, Fanigliulo L, Aragona G, et al. Quality of life in uncomplicated symptomatic diverticular disease: is it another good reason for treatment? Dig Dis 2007 25 : 252 9.
120. Di Mario F, Aragona G, Leandro G, et al. Efficacy of mesalazine in the treatment of symptomatic diverticular disease. Dig Dis Sci 2005 50 : 581 6.
121. Kruis W, Meier E, Schumacher M, et al. Treatment of painful diverticular disease of the colon with mesalamine: a placebo-controlled study. Gastroenterology 2007 132 : A 191. (Abstract S1187).
122. Tursi A, Brandimarte G, Daffinà R. Long-term treatment with mesalazine and rifaximin versus rifaximin alone for patients with recurrent attacks of acute diverticulitis of colon. Dig Liver Dis 2002 34 : 510 5.
123. Tursi A, Brandimarte G, Giorgetti GM, et al. Mesalazine and/or Lactobacillus casei in preventing recurrence of symptomatic uncomplicated diverticular disease of the colon: a prospective, randomized, open-label study. J Clin Gastroenterol 2006 40 : 312 6.
124. Tursi A, Brandimarte G, Giorgetti GM, et al. Balsalazide and/or high-potency probiotic mixture (VSL#3) in maintaining remission after attack of acute, uncomplicated diverticulitis of the colon. Int J Colorectal Dis 2007 22 : 1103 8.
125. Tursi A, Brandimarte G, Giorgetti GM, et al. Continuous versus cyclic mesalazine therapy for patients affected by recurrent symptomatic uncomplicated diverticular disease of the colon. Dig Dis Sci 2007 52 : 671 4.
126. Trespi E, Colla C, Panizza P, et al. [Therapeutic and prophylactic role of mesalazine (5-ASA) in symptomatic diverticular disease of the large intestine. 4 year follow-up results]. Minerva Gastroenterol Dietol 1999 45 : 245 52.
127. Guarner F, Schaafsma GJ. Probiotics. Int J Food Microbiol 1998 39 : 237 8.
128. Gionchetti P, Amadini C, Rizzello F, et al. Probiotics - role in inflammatory bowel disease. Dig Liver Dis 2002 34 (Suppl 2) S58 62.
129. Quigley EM. Probiotics in the management of colonic disorders. Curr Gastroenterol Rep. 2007 9 : 434 40.
130. Sanders ME. Probiotics. Food Technology 1999 53 : 66 77.
131. Giaccari S, Tronci S, Falconieri M, et al. Long-term treatment with rifaximin and lactobacilli in post-diverticulitic stenoses of the colon. Riv Eur Sci Med Farmacol 1993 15 : 29 34.
132. Fric P, Zavoral M. The effect of non-pathogenic Escherichia coli in symptomatic uncomplicated diverticular disease of the colon. Eur J Gastroenterol Hepatol 2003 15 : 313 5.
133. Borruel N, Casellas F, Antolin M, et al. Effects of nonpathogenic bacteria on cytokine secretion by human intestinal mucosa. Am J Gastroenterol 2003 98 : 865 70.